{"url_path":"/sec/mens/10-k/2026/item-11","section_key":"item-11","section_title":"Item 11 QUANTITATIVE AND QUALITATIVE DISCLOSURES","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1954488/0001213900-26-057073-index.html","accession_number":"0001213900-26-057073","cik":"0001954488","ticker":"MENS","issuer_name":"Jyong Biotech Ltd.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1954488/0001213900-26-057073-index.html","primary_entity_key":"0001954488","primary_entity_name":"Jyong Biotech Ltd."},"word_count":359,"has_tables":true,"body_markdown":"**Item 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES\nABOUT MARKET RISK**\n\n** **\n\n**Interest and Credit Risk**\n\n \n\nOur interest rate risk arises primarily from bank\nborrowing bearing interest based on floating rates. We currently do not have any interest rate hedging policy and have not historically\nused any derivative financial instruments to manage our interest risk exposure. As of December 31, 2024 and 2025, it is estimated\nthat a general increase of 100 basis points in interest rate, with all other variables held constant, would have increased our pre-tax loss\nfor the year by US$21 thousand and US$21 thousand, respectively.\n\n \n\nOur credit risk is primarily attributable to cash.\nWe mainly place or invest cash with reputable financial institutions in the jurisdictions where we and our subsidiaries are located. We\ndo not believe that our cash has significant risk of default or illiquidity, and we will continually monitor the credit worthiness of\nthese financial institutions. While we believe our cash does not contain excessive risk, future investments may be subject to adverse\nchanges in market value.\n\n \n\nAssets that potentially subject us to significant\nconcentration of credit risk primarily consist of cash. We expect that there is no significant credit risk associated with our cash, which\nwere held by reputable financial institutions in the jurisdictions where we and our subsidiaries are located. We believe that it is not\nexposed to unusual risks as these financial institutions have high credit quality.\n\n** **\n\n152\n\n \n\n** **\n\n**Liquidity Risk**\n\n \n\nWe manage liquidity risk by monitoring and maintaining\na level of cash deemed adequate to finance its operations and mitigate the effects of fluctuations in cash flows. In addition, management\nmonitors the utilization of bank borrowings and ensures compliance with loan covenants.\n\n** **\n\n**Foreign Currency Exchange Rate Risk**\n\n \n\nFluctuations in exchange rates may adversely\naffect our financial results. Our functional currency is the U.S. dollar, but the functional currency for each of our foreign subsidiaries\nis the local currency. As a result, certain of our assets and liabilities which were not denominated in U.S. dollar are sensitive\nto foreign currency exchange rate fluctuations. As of December 31, 2025, substantially all of our total assets and liabilities were\ndenominated in the NTD and RMB."}